JP2018533375A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018533375A5 JP2018533375A5 JP2018542995A JP2018542995A JP2018533375A5 JP 2018533375 A5 JP2018533375 A5 JP 2018533375A5 JP 2018542995 A JP2018542995 A JP 2018542995A JP 2018542995 A JP2018542995 A JP 2018542995A JP 2018533375 A5 JP2018533375 A5 JP 2018533375A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- cas9 molecule
- targeting domain
- gene
- hsv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002773 nucleotide Substances 0.000 claims 206
- 125000003729 nucleotide group Chemical group 0.000 claims 206
- 108091033409 CRISPR Proteins 0.000 claims 159
- 230000008685 targeting Effects 0.000 claims 116
- 108020005004 Guide RNA Proteins 0.000 claims 50
- 238000010362 genome editing Methods 0.000 claims 47
- 230000000295 complement effect Effects 0.000 claims 43
- 241000193996 Streptococcus pyogenes Species 0.000 claims 38
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims 30
- 241000700584 Simplexvirus Species 0.000 claims 28
- 101150087673 RL2 gene Proteins 0.000 claims 25
- 101150084777 RS1 gene Proteins 0.000 claims 25
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims 20
- 101150086595 lat gene Proteins 0.000 claims 15
- 239000013598 vector Substances 0.000 claims 14
- 108090000623 proteins and genes Proteins 0.000 claims 12
- 210000004027 cell Anatomy 0.000 claims 11
- 108700023549 Human herpesvirus 2 LAT Proteins 0.000 claims 10
- 108700005077 Viral Genes Proteins 0.000 claims 10
- 238000003776 cleavage reaction Methods 0.000 claims 6
- 230000000694 effects Effects 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 230000007017 scission Effects 0.000 claims 6
- 108091033319 polynucleotide Proteins 0.000 claims 4
- 239000002157 polynucleotide Substances 0.000 claims 4
- 102000040430 polynucleotide Human genes 0.000 claims 4
- 108091026890 Coding region Proteins 0.000 claims 3
- 230000035772 mutation Effects 0.000 claims 3
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims 2
- 108091092724 Noncoding DNA Proteins 0.000 claims 2
- 230000005783 single-strand break Effects 0.000 claims 2
- 108020005345 3' Untranslated Regions Proteins 0.000 claims 1
- 108020003589 5' Untranslated Regions Proteins 0.000 claims 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000004075 alteration Effects 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 210000002919 epithelial cell Anatomy 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 230000003834 intracellular effect Effects 0.000 claims 1
- 210000003061 neural cell Anatomy 0.000 claims 1
- 108091008695 photoreceptors Proteins 0.000 claims 1
- 230000008488 polyadenylation Effects 0.000 claims 1
- 125000006850 spacer group Chemical group 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022007688A JP2022068156A (ja) | 2015-10-30 | 2022-01-21 | 単純ヘルペスウイルスを治療するためのｃｒｉｓｐｒ／ｃａｓ関連方法及び組成物 |
| JP2023206552A JP2024055867A (ja) | 2015-10-30 | 2023-12-07 | 単純ヘルペスウイルスを治療するためのｃｒｉｓｐｒ／ｃａｓ関連方法及び組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562249071P | 2015-10-30 | 2015-10-30 | |
| US201562249159P | 2015-10-30 | 2015-10-30 | |
| US62/249,159 | 2015-10-30 | ||
| US62/249,071 | 2015-10-30 | ||
| PCT/US2016/059502 WO2017075475A1 (en) | 2015-10-30 | 2016-10-28 | Crispr/cas-related methods and compositions for treating herpes simplex virus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022007688A Division JP2022068156A (ja) | 2015-10-30 | 2022-01-21 | 単純ヘルペスウイルスを治療するためのｃｒｉｓｐｒ／ｃａｓ関連方法及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018533375A JP2018533375A (ja) | 2018-11-15 |
| JP2018533375A5 true JP2018533375A5 (cg-RX-API-DMAC7.html) | 2019-12-05 |
| JP7408284B2 JP7408284B2 (ja) | 2024-01-05 |
Family
ID=57321423
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018542995A Active JP7408284B2 (ja) | 2015-10-30 | 2016-10-28 | 単純ヘルペスウイルスを治療するためのｃｒｉｓｐｒ／ｃａｓ関連方法及び組成物 |
| JP2022007688A Withdrawn JP2022068156A (ja) | 2015-10-30 | 2022-01-21 | 単純ヘルペスウイルスを治療するためのｃｒｉｓｐｒ／ｃａｓ関連方法及び組成物 |
| JP2023206552A Pending JP2024055867A (ja) | 2015-10-30 | 2023-12-07 | 単純ヘルペスウイルスを治療するためのｃｒｉｓｐｒ／ｃａｓ関連方法及び組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022007688A Withdrawn JP2022068156A (ja) | 2015-10-30 | 2022-01-21 | 単純ヘルペスウイルスを治療するためのｃｒｉｓｐｒ／ｃａｓ関連方法及び組成物 |
| JP2023206552A Pending JP2024055867A (ja) | 2015-10-30 | 2023-12-07 | 単純ヘルペスウイルスを治療するためのｃｒｉｓｐｒ／ｃａｓ関連方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11001844B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3368670A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7408284B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN109312338B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2016343991B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3001711A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017075475A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2853829C (en) | 2011-07-22 | 2023-09-26 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
| US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US20150166982A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting pi3k point mutations |
| EP3092049A1 (en) | 2014-01-08 | 2016-11-16 | Flodesign Sonics Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| EP3177718B1 (en) | 2014-07-30 | 2022-03-16 | President and Fellows of Harvard College | Cas9 proteins including ligand-dependent inteins |
| MA41349A (fr) * | 2015-01-14 | 2017-11-21 | Univ Temple | Éradication de l'herpès simplex de type i et d'autres virus de l'herpès associés guidée par arn |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| SG11201803173VA (en) | 2015-10-23 | 2018-05-30 | Harvard College | Nucleobase editors and uses thereof |
| WO2017189959A1 (en) | 2016-04-29 | 2017-11-02 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| US11299751B2 (en) | 2016-04-29 | 2022-04-12 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| JP7231935B2 (ja) | 2016-08-03 | 2023-03-08 | プレジデント アンド フェローズ オブ ハーバード カレッジ | アデノシン核酸塩基編集因子およびそれらの使用 |
| CA3033327A1 (en) | 2016-08-09 | 2018-02-15 | President And Fellows Of Harvard College | Programmable cas9-recombinase fusion proteins and uses thereof |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| WO2018071868A1 (en) | 2016-10-14 | 2018-04-19 | President And Fellows Of Harvard College | Aav delivery of nucleobase editors |
| WO2018081504A1 (en) * | 2016-10-28 | 2018-05-03 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating herpes simplex virus |
| US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
| US12390514B2 (en) | 2017-03-09 | 2025-08-19 | President And Fellows Of Harvard College | Cancer vaccine |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| JP2020510439A (ja) | 2017-03-10 | 2020-04-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | シトシンからグアニンへの塩基編集因子 |
| KR20240116572A (ko) | 2017-03-23 | 2024-07-29 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제 |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| EP3658573A1 (en) | 2017-07-28 | 2020-06-03 | President and Fellows of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| WO2019139645A2 (en) | 2017-08-30 | 2019-07-18 | President And Fellows Of Harvard College | High efficiency base editors comprising gam |
| AU2018352592C1 (en) | 2017-10-16 | 2025-09-25 | Beam Therapeutics, Inc. | Uses of adenosine base editors |
| JP2021507561A (ja) | 2017-12-14 | 2021-02-22 | フロデザイン ソニックス， インク．Ｆｌｏｄｅｓｉｇｎ Ｓｏｎｉｃｓ， Ｉｎｃ． | 音響トランスデューサドライバ及びコントローラ |
| EP3724214A4 (en) | 2017-12-15 | 2021-09-01 | The Broad Institute Inc. | SYSTEMS AND METHODS FOR PREDICTING REPAIR RESULTS IN GENETIC ENGINEERING |
| EP3746554A1 (en) * | 2018-01-30 | 2020-12-09 | Editas Medicine, Inc. | Systems and methods for modulating chromosomal rearrangements |
| WO2019152868A1 (en) * | 2018-02-01 | 2019-08-08 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating herpes simplex virus (hsv) related keratitis |
| CN112041444A (zh) | 2018-03-14 | 2020-12-04 | 阿伯生物技术公司 | 新型crispr dna靶向酶及系统 |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| WO2020055941A1 (en) * | 2018-09-13 | 2020-03-19 | Excision Biotherapeutics, Inc. | Compositions and methods for excision with single grna |
| US12281338B2 (en) | 2018-10-29 | 2025-04-22 | The Broad Institute, Inc. | Nucleobase editors comprising GeoCas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| EP3918071A1 (en) * | 2019-02-01 | 2021-12-08 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions targeting virus genomes |
| GB2601617B (en) | 2019-03-19 | 2024-02-21 | Broad Inst Inc | Methods and compositions for editing nucleotide sequences |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| CN115379850A (zh) | 2019-12-24 | 2022-11-22 | 裘美娜治疗公司 | 再生性多肽及其用途 |
| DE112021002672T5 (de) | 2020-05-08 | 2023-04-13 | President And Fellows Of Harvard College | Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz |
| WO2022006745A1 (en) * | 2020-07-07 | 2022-01-13 | Oriengene Biotechnology Ltd | Guide rna for hsv-1 gene editing and method thereof |
| WO2022071974A1 (en) * | 2020-10-02 | 2022-04-07 | Temple University - Of The Commonwealth System Of Higher Education | Rna guided eradication of herpes simplex type i and other related human herpesviruses |
| EP4288541A1 (en) | 2021-02-05 | 2023-12-13 | Christiana Care Gene Editing Institute, Inc. | Methods of and compositions for reducing gene expression and/or activity |
| WO2022271466A1 (en) * | 2021-06-21 | 2022-12-29 | Juvena Therapeutics, Inc. | Regenerative polypeptides and uses thereof |
| WO2024113302A1 (zh) * | 2022-12-01 | 2024-06-06 | 深圳先进技术研究院 | 靶向HSV必需基因的gRNA、CRISPR/Cas基因编辑系统、递送系统及应用 |
| CN116121271B (zh) * | 2022-12-21 | 2025-05-09 | 四川农业大学 | 多杀性巴氏杆菌arcA基因及其应用 |
| US12227748B1 (en) * | 2024-04-25 | 2025-02-18 | King Saud University | Aptamers for binding to a membrane-based lipid |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9102126D0 (en) * | 1991-01-31 | 1991-03-13 | Smithkline Beecham Biolog | Novel vaccine |
| US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
| US5725493A (en) | 1994-12-12 | 1998-03-10 | Avery; Robert Logan | Intravitreal medicine delivery |
| US6299895B1 (en) | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
| JP4837861B2 (ja) | 1999-10-21 | 2011-12-14 | アルコン，インコーポレイティド | ドラッグデリバリ製剤 |
| US6416777B1 (en) | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
| US7074596B2 (en) | 2002-03-25 | 2006-07-11 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Synthesis and use of anti-reverse mRNA cap analogues |
| US7795419B2 (en) * | 2004-05-26 | 2010-09-14 | Rosetta Genomics Ltd. | Viral and viral associated miRNAs and uses thereof |
| CA2659301A1 (en) | 2006-07-28 | 2008-02-07 | Applera Corporation | Dinucleotide mrna cap analogs |
| WO2009024834A2 (en) * | 2006-12-05 | 2009-02-26 | Rosetta Genomics Ltd | Nucleic acids involved in viral infection |
| WO2008157688A2 (en) | 2007-06-19 | 2008-12-24 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap |
| PL215513B1 (pl) | 2008-06-06 | 2013-12-31 | Univ Warszawski | Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka |
| WO2013059475A1 (en) | 2011-10-18 | 2013-04-25 | Life Technologies Corporation | Alkynyl-derivatized cap analogs, preparation and uses thereof |
| EP2931898B1 (en) * | 2012-12-12 | 2016-03-09 | The Broad Institute, Inc. | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains |
| CN111218447B (zh) * | 2013-11-07 | 2024-10-11 | 爱迪塔斯医药有限公司 | 使用统治型gRNA的CRISPR相关方法和组合物 |
| MX374530B (es) | 2013-12-12 | 2025-03-06 | Broad Inst Inc | Suministro, uso y aplicaciones terapeuticas de los sistemas y composiciones crispr-cas para actuar sobre hbv y trastornos y enfermedades virales. |
| US10286084B2 (en) * | 2014-02-18 | 2019-05-14 | Duke University | Compositions for the inactivation of virus replication and methods of making and using the same |
| CA2943622A1 (en) * | 2014-03-25 | 2015-10-01 | Editas Medicine Inc. | Crispr/cas-related methods and compositions for treating hiv infection and aids |
| WO2015153791A1 (en) * | 2014-04-01 | 2015-10-08 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating herpes simplex virus type 2 (hsv-2) |
| EP4123024B1 (en) * | 2014-04-01 | 2024-12-18 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating herpes simplex virus type 1 (hsv-1) |
| US10507232B2 (en) * | 2014-04-02 | 2019-12-17 | University Of Florida Research Foundation, Incorporated | Materials and methods for the treatment of latent viral infection |
| KR102595473B1 (ko) * | 2014-04-18 | 2023-10-30 | 에디타스 메디신, 인코포레이티드 | 암 면역요법을 위한 crispr-cas-관련 방법, 조성물 및 구성성분 |
| US11254933B2 (en) | 2014-07-14 | 2022-02-22 | The Regents Of The University Of California | CRISPR/Cas transcriptional modulation |
| US10071098B2 (en) * | 2014-09-26 | 2018-09-11 | Drexel University | Compositions useful for treating herpes simplex labialis and/or herpes esophagitis, and methods using same |
| MA41349A (fr) * | 2015-01-14 | 2017-11-21 | Univ Temple | Éradication de l'herpès simplex de type i et d'autres virus de l'herpès associés guidée par arn |
| CA2981508A1 (en) | 2015-04-01 | 2016-10-06 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy and becker muscular dystrophy |
| JP7272952B2 (ja) * | 2016-12-05 | 2023-05-12 | エディタス・メディシン、インコーポレイテッド | 内因性および起源ＤＮＡのワンショットガイドＲＮＡ（ｏｇＲＮＡ）標的化のためのシステムおよび方法 |
-
2016
- 2016-10-28 CA CA3001711A patent/CA3001711A1/en active Pending
- 2016-10-28 AU AU2016343991A patent/AU2016343991B2/en active Active
- 2016-10-28 EP EP16795487.4A patent/EP3368670A1/en active Pending
- 2016-10-28 CN CN201680074667.3A patent/CN109312338B/zh active Active
- 2016-10-28 JP JP2018542995A patent/JP7408284B2/ja active Active
- 2016-10-28 WO PCT/US2016/059502 patent/WO2017075475A1/en not_active Ceased
- 2016-10-28 CN CN202211088995.2A patent/CN115491373A/zh active Pending
-
2018
- 2018-04-30 US US15/966,897 patent/US11001844B2/en active Active
-
2021
- 2021-04-19 US US17/234,145 patent/US11834649B2/en active Active
-
2022
- 2022-01-21 JP JP2022007688A patent/JP2022068156A/ja not_active Withdrawn
- 2022-11-14 AU AU2022271376A patent/AU2022271376B9/en active Active
-
2023
- 2023-12-07 JP JP2023206552A patent/JP2024055867A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018533375A5 (cg-RX-API-DMAC7.html) | ||
| Peng et al. | Engineering canker‐resistant plants through CRISPR/Cas9‐targeted editing of the susceptibility gene Cs LOB 1 promoter in citrus | |
| US12431216B2 (en) | Methods for identifying class 2 crispr-cas systems | |
| Tsai et al. | Complete genome sequence of the grouper iridovirus and comparison of genomic organization with those of other iridoviruses | |
| Gentile et al. | More evidence of collusion: a new prophage-mediated viral defense system encoded by mycobacteriophage Sbash | |
| CN103088008B (zh) | 胞苷脱氨酶及其编码基因和它们的应用 | |
| Suenaga et al. | Engineering large viral DNA genomes using the CRISPR‐Cas9 system | |
| EP3178935B1 (en) | Genome editing using campylobacter jejuni crispr/cas system-derived rgen | |
| JP2018534950A5 (cg-RX-API-DMAC7.html) | ||
| JP2016504026A5 (cg-RX-API-DMAC7.html) | ||
| JP2019524098A5 (cg-RX-API-DMAC7.html) | ||
| JP2019115348A5 (cg-RX-API-DMAC7.html) | ||
| Lee et al. | Precise gene editing of chicken Na+/H+ exchange type 1 (chNHE1) confers resistance to avian leukosis virus subgroup J (ALV-J) | |
| Mei et al. | The C4 protein encoded by tomato leaf curl Yunnan virus reverses transcriptional gene silencing by interacting with NbDRM2 and impairing its DNA-binding ability | |
| JP2016501532A5 (cg-RX-API-DMAC7.html) | ||
| JP2016165307A5 (cg-RX-API-DMAC7.html) | ||
| JPH11253177A5 (cg-RX-API-DMAC7.html) | ||
| WO2015115903A1 (en) | Site-specific dna break-induced genome editing using engineered nucleases | |
| CN102703424B (zh) | 一种重组工程介导的大肠杆菌基因组点突变的方法 | |
| Senčilo et al. | A glimpse of the genomic diversity of haloarchaeal tailed viruses | |
| Walter et al. | Viral gene drive in herpesviruses | |
| CN114144519B (zh) | 单碱基置换蛋白以及包含其的组合物 | |
| Ke et al. | Divergent transcriptomic responses underlying the ranaviruses-amphibian interaction processes on interspecies infection of Chinese giant salamander | |
| JP7489112B2 (ja) | Ｃｒｉｓｐｒタイプｉ－ｄシステムを利用した標的配列改変技術 | |
| Guo et al. | Highly efficient CRISPR/Cas9-mediated homologous recombination promotes the rapid generation of bacterial artificial chromosomes of pseudorabies virus |